• Make it like cafepharma, but for different industries: over the years we’ve had suggestions for creating a site similar to cafepharma, but for different industries. Now there is a place. Check out CompanyUnderground for company forums in other industries. Don’t see a company? Request it here. Let your friends and family outside the pharma/medical sales space know they now have a safe, anonymous place to talk.


New Ocrevus CFO Structure

anonymous

Guest
Bloodletting not as bad as expected, but still.... Details to be shared with field leadership on Thursday, rest of field will know by Friday (here is a preview)

CURRENTLY
1 NSD
3 RSDs
20 DMs
152 CS (positions not actual, as there are some vacancies)

1 CC AD
3 CC AMs
20 CCs

1 NFRM
4 NFRM AMs
28 NFRMs

MOVING FORWARD
1 NSD
4 RSDs
16 DMs
120 CS

8 Clinical Reimbursement Specialists (CRS) Area Managers
48 CRS

The CRS AMs will report into the RSD. RSD will have 4 DMs & 2 CRS AMs each.

No more CC or NFRM roles. The CRS will be a hybrid of both CC / NFRM.
 


















Bloodletting not as bad as expected, but still.... Details to be shared with field leadership on Thursday, rest of field will know by Friday (here is a preview)

CURRENTLY
1 NSD
3 RSDs
20 DMs
152 CS (positions not actual, as there are some vacancies)

1 CC AD
3 CC AMs
20 CCs

1 NFRM
4 NFRM AMs
28 NFRMs

MOVING FORWARD
1 NSD
4 RSDs
16 DMs
120 CS

8 Clinical Reimbursement Specialists (CRS) Area Managers
48 CRS

The CRS AMs will report into the RSD. RSD will have 4 DMs & 2 CRS AMs each.

No more CC or NFRM roles. The CRS will be a hybrid of both CC / NFRM.

This is a bloodbath.
 






This is a complete bogus post. Do not believe anything this idiot wrote. This is not going to happen! I simply can’t understand why someone gets kicks out spooking people out with such false information. Karma is a bitch and they will get theirs in the end.
 






CS positions will be fine. The neurology franchise is what Genentech is holding their hat on right now. Quiet and prolonged periods of time before final plans are unveiled always can make anyone anxious but they certainly don’t want to shave off exceptional talent. Especially, with a concentrated pipeline in the neurology space just a year or two out, they will not let go of the talent they collected. Building a sales team costs corporations multi millions and they don’t want to cut off what is fueling the company, not to mention the negative media this would create.
 






CS positions will be fine. The neurology franchise is what Genentech is holding their hat on right now. Quiet and prolonged periods of time before final plans are unveiled always can make anyone anxious but they certainly don’t want to shave off exceptional talent. Especially, with a concentrated pipeline in the neurology space just a year or two out, they will not let go of the talent they collected. Building a sales team costs corporations multi millions and they don’t want to cut off what is fueling the company, not to mention the negative media this would create.


A lot of the Neurology Franchise “exceptional talent” is looking right now as a result of the lack of transparency during transformation. <- whatever the heck that actually means. ( Rightsizing, Downsizing, Reorganization, etc )

What is sad, is that after the most successful launch in Genentech history as a result of those exceptionally talented people that left great careers at their former companies, they now have to question whether they will have a job in July. I find it unfortunate that the true character of Genentech may not have been what we thought it was when we made the decision to come here. If CS’s are impacted adversely after what they just did for Genentech it will be inexcusable. I hate to burst the ivory tower bubble in San Fran but the CS’s in the field, and their relationships, made the majority of this launch successful. Marketing, Management, Leadership, and others were a very small part of this success. It’s time someone gave these egotistical folks a lesson in how actual Sales happen. I’m waiting for my thank you in the form of ending this total distraction from my daily activities in the field.
 






A lot of the Neurology Franchise “exceptional talent” is looking right now as a result of the lack of transparency during transformation. <- whatever the heck that actually means. ( Rightsizing, Downsizing, Reorganization, etc )

What is sad, is that after the most successful launch in Genentech history as a result of those exceptionally talented people that left great careers at their former companies, they now have to question whether they will have a job in July. I find it unfortunate that the true character of Genentech may not have been what we thought it was when we made the decision to come here. If CS’s are impacted adversely after what they just did for Genentech it will be inexcusable. I hate to burst the ivory tower bubble in San Fran but the CS’s in the field, and their relationships, made the majority of this launch successful. Marketing, Management, Leadership, and others were a very small part of this success. It’s time someone gave these egotistical folks a lesson in how actual Sales happen. I’m waiting for my thank you in the form of ending this total distraction from my daily activities in the field.

Totally agree! Putting us through hell!
 






Everyone needs to take a chill pill! Whoever started this thread, is a complete asshole. They are not going to reduce the salesforce. If anything, they will be needing to add to the salesforce sooner than later with the vision they have in mind for neuroscience market. I do however agree that their tactics with transformation have not been conducted in an appropriate manner. The company has been very fortunate to have acquired really strong talent and the neuroscience space hand it would be reckless to let anyone go at this point. A good company and not an average company, always takes care of its people.
 






Everyone needs to take a chill pill! Whoever started this thread, is a complete asshole. They are not going to reduce the salesforce. If anything, they will be needing to add to the salesforce sooner than later with the vision they have in mind for neuroscience market. I do however agree that their tactics with transformation have not been conducted in an appropriate manner. The company has been very fortunate to have acquired really strong talent and the neuroscience space hand it would be reckless to let anyone go at this point. A good company and not an average company, always takes care of its people.
Dont look over there, folks, look over here.
 












The real truth is that Leadership knows there will be reductions in the field force. If not, why haven’t they made it crystal clear to all of us that we are safe?
We will lose, and in fact, have already lost some very talented Neurology folks. It will once again come down to favortism in the Management Ranks on who stays and who goes. Will any of our Management Team make the tough decision and lay off a Genentech Legacy over one of our new Neurology Talents that bought the bait and switch deal 2 years ago? Doubt it. Brown noses and short skirts will survive. Politically incorrect Truth hurts. Prove me wrong.
 






Non-Ocre GNE here - heard about the debacle you all are facing - my sincerest best wishes. I have been through a couple of downsizings at GNE over the years, figured I would share how it usually goes down for sales. (Don't know anything about the other roles)
  • Mapping of people to positions will be driven by Sales Ops & HR based on existing "formulas" that the NSD / Franchise Head will advise on.
  • The NSD / DMs / RSDs will not have input on who gets to stay / who goes - this is due to liability concerns (those displaced will not be able to make a case of "favoritism").
  • Primary driver in formula is always geography (how close do you live to the center of business)
  • Secondary drivers in formula in no particular order (varies): personnel ratings, tenure, market experience, etc. All things that cannot be changed or be "subjective", again due to liability concerns.
  • "Ranking" is never one of the criteria because of discrepancies, variability in territory, etc
  • After folks are mapped, they then do a secondary round of mapping of the displaced folks to territories within a certain mile radius (varies) - you will have option to decline and receive severance
  • If you are the primary "winner" you usually cannot opt out for a severence unless there is a displaced person in your area, then maybe
  • The actual knowledge of whom gets mapped / displaced is usually shared with RSDs on Day 1, DMs on Day 2, CS on Day 3. RSD / DM will risk termination if disclose ahead of time, so no use inquiring.
  • Severance amount varies each time so there is no rule that I am aware of
From what I hear all of this is going down by end of June...good luck...

FYI "Ocre-versy" is the lingo being used to describe what you all are going through. (as in contro-versy not anni-versary)
 






Non-Ocre GNE here - heard about the debacle you all are facing - my sincerest best wishes. I have been through a couple of downsizings at GNE over the years, figured I would share how it usually goes down for sales. (Don't know anything about the other roles)
  • Mapping of people to positions will be driven by Sales Ops & HR based on existing "formulas" that the NSD / Franchise Head will advise on.
  • The NSD / DMs / RSDs will not have input on who gets to stay / who goes - this is due to liability concerns (those displaced will not be able to make a case of "favoritism").
  • Primary driver in formula is always geography (how close do you live to the center of business)
  • Secondary drivers in formula in no particular order (varies): personnel ratings, tenure, market experience, etc. All things that cannot be changed or be "subjective", again due to liability concerns.
  • "Ranking" is never one of the criteria because of discrepancies, variability in territory, etc
  • After folks are mapped, they then do a secondary round of mapping of the displaced folks to territories within a certain mile radius (varies) - you will have option to decline and receive severance
  • If you are the primary "winner" you usually cannot opt out for a severence unless there is a displaced person in your area, then maybe
  • The actual knowledge of whom gets mapped / displaced is usually shared with RSDs on Day 1, DMs on Day 2, CS on Day 3. RSD / DM will risk termination if disclose ahead of time, so no use inquiring.
  • Severance amount varies each time so there is no rule that I am aware of
From what I hear all of this is going down by end of June...good luck...

FYI "Ocre-versy" is the lingo being used to describe what you all are going through. (as in contro-versy not anni-versary)

Thanks for your what seems to be a sincere response, although the bottom line still seems like a crapshoot of what might happen. What kind of source are you finding this out from?
 






Non-Ocre GNE here - heard about the debacle you all are facing - my sincerest best wishes. I have been through a couple of downsizings at GNE over the years, figured I would share how it usually goes down for sales. (Don't know anything about the other roles)
  • Mapping of people to positions will be driven by Sales Ops & HR based on existing "formulas" that the NSD / Franchise Head will advise on.
  • The NSD / DMs / RSDs will not have input on who gets to stay / who goes - this is due to liability concerns (those displaced will not be able to make a case of "favoritism").
  • Primary driver in formula is always geography (how close do you live to the center of business)
  • Secondary drivers in formula in no particular order (varies): personnel ratings, tenure, market experience, etc. All things that cannot be changed or be "subjective", again due to liability concerns.
  • "Ranking" is never one of the criteria because of discrepancies, variability in territory, etc
  • After folks are mapped, they then do a secondary round of mapping of the displaced folks to territories within a certain mile radius (varies) - you will have option to decline and receive severance
  • If you are the primary "winner" you usually cannot opt out for a severence unless there is a displaced person in your area, then maybe
  • The actual knowledge of whom gets mapped / displaced is usually shared with RSDs on Day 1, DMs on Day 2, CS on Day 3. RSD / DM will risk termination if disclose ahead of time, so no use inquiring.
  • Severance amount varies each time so there is no rule that I am aware of
From what I hear all of this is going down by end of June...good luck...

FYI "Ocre-versy" is the lingo being used to describe what you all are going through. (as in contro-versy not anni-versary)
As someone who just experienced BOLD your response is appreciated but let's not kid ourselves, there's a lot of subjectivity involved behind the scenes. They just try to mask it with plausible arguments. Good luck all!
 


















As one who left on their own accord and having been in a disadvantaged territory (major non-340b account not getting reimbursed along with step edits for cost) for years with no correction to goals, being in a lower ranked territory does lead to significant pressure from leadership. Sticking it out and likely getting a needs improvement followed by a PIP is not worth the aggravation. They’re using rankings to push out those in the bottom 10%, don’t think otherwise. Take control of your career is all I’ll say.
 






Bloodletting not as bad as expected, but still.... Details to be shared with field leadership on Thursday, rest of field will know by Friday (here is a preview)

CURRENTLY
1 NSD
3 RSDs
20 DMs
152 CS (positions not actual, as there are some vacancies)

1 CC AD
3 CC AMs
20 CCs

1 NFRM
4 NFRM AMs
28 NFRMs

MOVING FORWARD
1 NSD
4 RSDs
16 DMs
120 CS

8 Clinical Reimbursement Specialists (CRS) Area Managers
48 CRS

The CRS AMs will report into the RSD. RSD will have 4 DMs & 2 CRS AMs each.

No more CC or NFRM roles. The CRS will be a hybrid of both CC / NFRM.

How close is this?